Mark A. Gohr
Financieel Directeur/CFO bij ANTH1, Inc.
Oorsprong van het eerstegraads netwerk van Mark A. Gohr
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
ANTH1, Inc.
 ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO.
3
| Private Company | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mark A. Gohr via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of Illinois | College/University | Undergraduate Degree | |
| The University of Colorado | College/University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Sectoraal
| Consumer Services | 3 |
Operationeel
| President | 2 |
| Undergraduate Degree | 2 |
| Chief Executive Officer | 1 |
| Corporate Secretary | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Jeffrey W. Villano | 2 |
| James J. Tufts | 2 |
| Larry A. Gelhaar | 1 |
- Beurs
- Insiders
- Mark A. Gohr
- Bedrijfsconnecties
